Hey, you guys can bet all you want. I just want to  gasak.   

 

Totally agree!

iPunter      ( Date: 31-May-2012 11:01) Posted: What is there to be scared of in betting?     If charts can predict the outcome, then what is there to bet?               Thus, it is chart-based betting... better than to gasak...               fortunecat      ( Date: 31-May-2012 10:41) Posted: but when people see charts and try to determine the point to buy/sell, you always  come out and scare them saying that everything is just a bet and charts can't tell the future. like that how lo

 

sifu IP is right..

charts/TA can never predict future. only show one what are the possible outcomes..

a strong buy signal/entry point can be also a strong sell   signal/entry point..

to each his own bets/punt... otherwise will not have to add DYODD as disclaimer liao... 

Today looking cheap... tmr cheaper.. LOL

iPunter      ( Date: 31-May-2012 11:01) Posted: What is there to be scared of in betting?     If charts can predict the outcome, then what is there to bet?               Thus, it is chart-based betting... better than to gasak...               fortunecat      ( Date: 31-May-2012 10:41) Posted: but when people see charts and try to determine the point to buy/sell, you always  come out and scare them saying that everything is just a bet and charts can't tell the future. like that how lo

 

Got dump again. Good luck. 

 

What is there to be scared of in betting?

    If charts can predict the outcome, then what is there to bet?

              Thus, it is chart-based betting... better than to gasak...              

fortunecat      ( Date: 31-May-2012 10:41) Posted: but when people see charts and try to determine the point to buy/sell, you always  come out and scare them saying that everything is just a bet and charts can't tell the future. like that how lol iPunter      ( Date: 30-May-2012 20:55) Posted: You have to do a bit of work with the charts...     A good starting point is to scan all the stocks' charts every evening...

 

but when people see charts and try to determine the point to buy/sell, you always  come out and scare them saying that everything is just a bet and charts can't tell the future. like that how lol

iPunter      ( Date: 30-May-2012 20:55) Posted: You have to do a bit of work with the charts...     A good starting point is to scan all the stocks' charts every evening... junction      ( Date: 30-May-2012 10:32) Posted: You are right of course. Its every investor/trader's dream to sell high and buy low. The problem is how?

 

anybody know how to get " Free float" infomation???

topdog22      ( Date: 30-May-2012 08:55) Posted: CIMB  Analysis    By Gary NG Biosensors Int'l 4QFY12RESULTSNOTE BIG SP/ BIOS.SI Current S$1.29 SHORTTERM(3 MTH) LONG TERM Market Cap AvgDailyTurnover Free Float Target S$1.82 US$1,732m US$8.11m 42% Previous Target S$1.98 S$2,212m S$10.19m 1,721m shares Up/downside 41.6% Not a bad romance Resultsexceedmanagement’s guidance. After investors’ initial overreaction toprice-reduction fears in China, bargain valuationshaveemerged. We areoptimistic on product penetration in key Asia-Pacific markets. FY12 core meets 98% of Street and 104% of our expectations. We lower our margin assumptions conservatively on easing ASPs and reduced FY13-14 EPS, and our SOP target accordingly. Retain Outperform on market leadership and product superiority. FY12 recap 4Q12 revenue of S$88.2m (+98.2% yoy) was fired by strong growth in stent sales, boosted by the consolidation of JWMS. Licensing and royalty revenue grew to US$22.8m (+378.3% yoy), led by Nobori DES sales in Japan under Terumo. Gross margins improved sequentially to 82.0% on the back of lower JWMS consolidation costs and cost control. Demand in EMEA and Asia Pacific remains strong. In China, management has yet to discern any destocking in anticipation of weaker prices, as claimed by the Chinese media. FY13 guidance Management expects profitability to improve by 20-30% yoy in FY13. While scope for growth in licensing revenue is limited, sales volume in EMEA and Asia Pacific continues to gain traction, with greater marketing efforts and penetration. This should overwhelm easing ASPs. Management is still sanguine on BIG’s product superiority which should bestow higher spectrum pricing power. Catalysts SFDA approval for the launch of BioMatrix will be paramount for blunting the impact of any mandated price reductions (in China and Japan

 

You have to do a bit of work with the charts...

    A good starting point is to scan all the stocks' charts every evening...

junction      ( Date: 30-May-2012 10:32) Posted: You are right of course. Its every investor/trader's dream to sell high and buy low. The problem is how? iPunter      ( Date: 30-May-2012 09:43) Posted: Sell only at juicy peaks...     But buy only when there got no more juice left... lol...

 

Siao counter. It's back down to 1.28. At least, I know it's the bottom. I'll have to hold onto this baby till the euro crisis blows over and the siao Sinapore traders come crawling back out from their kiasu holes.

 

http://singaporetrader.wordpress.com/2012/05/30/biosensors-international-bright-spots-amid-asp-concerns/

 

You are right of course. Its every investor/trader's dream to sell high and buy low. The problem is how?

iPunter      ( Date: 30-May-2012 09:43) Posted: Sell only at juicy peaks...     But buy only when there got no more juice left... lol...  Bopanha      ( Date: 30-May-2012 09:12) Posted: Buy or sell also must have juice, otherwise you will still lose.  " Juice" is borrowed from sifu iPunter.

 

Price is at peak now? Well, market sentiment is bad, but in my opinion, this stock is clearly undervalued.

aleoleo      ( Date: 30-May-2012 10:15) Posted: today should be the last chance to escape from the peak ....

 

today should be the last chance to escape from the peak ....

 

Sell only at juicy peaks...

    But buy only when there got no more juice left... lol... 

Bopanha      ( Date: 30-May-2012 09:12) Posted: Buy or sell also must have juice, otherwise you will still lose.  " Juice" is borrowed from sifu iPunter.

 

OCBC

Biosensors International Group: FY12 results within expectations
Biosensors International Group (BIG) reported 4QFY12 revenue of US$88.2m (+98.2% YoY) and core PATMI of US$28.6m (71.5% YoY). For FY12, revenue increased 86.6% to US$292.1m, or 0.3% above our forecast. Core PATMI grew 92.0% to US$101.0m and formed 98.6% of our FY12 estimates. Looking ahead, we expect BIG’s growth trajectory to continue, although DES price reductions in various locations is expected to dampen its gross margin. Management guided that sales for FY13 would be in the range of 20-30%, which was below consensus’ estimates. We pare our FY13 revenue forecast by 4.2% and our PATMI estimates by 10.2%. This is partially mitigated as we also roll forward our DCF-based valuation. Maintain BUY with a lower fair value estimate of S$1.88 (previously S$1.92).

 

 

Waiting for more analyst to call, before we see bigger volumes?

 

After forming the rising wedge n fell heavily to $1.25 , Biosesors made a rapid rebounce n touching the lower part of the rising wegde at $1.32 today , it is still valid if it could not set off this formation with heavy volume .

susan66      ( Date: 28-May-2012 12:19) Posted: Thanks Bintang, I stay alert today, sold $1.32 since market sentiment not too good.  susan66      ( Date: 27-May-2012 22:44) Posted: Thanks shifu for the analysis, missed reading your post for qute sometime.  This rising wedge seems may continue another week or so if doesn't breakdown.  So needs to continue to monitor.  If it is able to stay > $1.32 next week, it may be able to test $1.40 at MA200, am I right? Of course, if it breaks down, we  have to put our stop loss accordingly.